T1	Outcomes 9 17	survival
T2	Outcomes 386 411	efficacy and tolerability
T3	Outcomes 806 814	efficacy
T4	Outcomes 818 851	time to disease progression (TTP)
T5	Outcomes 957 973	overall survival
T6	Outcomes 1063 1092	objective tumor response rate
T7	Outcomes 1139 1191	Gastrointestinal side effects and hand-foot syndrome
T8	Outcomes 1243 1262	myalgia, arthralgia
T9	Outcomes 1268 1292	neutropenic fever/sepsis
T10	Outcomes 1344 1366	grade 3 adverse events
T11	Outcomes 1436 1450	grade 4 events
T12	Outcomes 1560 1576	TTP and survival
T13	Outcomes 1665 1681	toxicity profile
